Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

"Studies indicate disability, poverty and inaccessibility to healthcare are intricately linked " - expert opinion by Dr Magteld Smith

2014-12-03

Dr Magteld Smith

Programmes worldwide attempt to improve the lives of people with disabilities, but recent studies indicated that disability and poverty, as well as disability and the inaccessibility of health care, continues to go hand in hand.

In South Africa, and even in developed countries, research shows that people with disabilities achieve lower levels of education with higher unemployment rates, live in extreme poverty and have low living standards.

“To have a disability can therefore become a huge financial burden on either the disabled person, the family or caregivers,” says Dr Magteld Smith from the Department of Otorhinolaryngology.

She devotes her research to the medical-social model of the global organisation, the International Classification of Functioning, Disabilities and Health, focusing on all areas of deafness.

Furthermore, Dr Smith says it is more difficult or more expensive for people with disabilities to obtain insurance, because of the risks associated with disability.

Dr Smith also emphasises the inaccessibility and even unavailability of medical services or health care for people with disabilities.

“Services such as psychiatry or social services are often not accessible. When such services are available, it is not affordable for most people with disabilities.”

Dr Smith uses the example of a person who was born deaf:

“Doctors have limited knowledge of the different types of hearing impairments or how to read and interpret an audiogram. Very little understanding also exists for the impact of deafness on the person’s daily life.”

Dr Smith, who is deaf herself, describes the emotional state of mind of people with disabilities as a daily process of adjustment and self-evaluation.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept